Severe and fulminant hepatitis of indeterminate etiology in a Japanese center

被引:18
|
作者
Fujiwara, Keiichi [1 ]
Yasui, Shin [1 ]
Nakano, Masayuki [4 ]
Yonemitsu, Yutaka [1 ]
Arai, Makoto [1 ]
Kanda, Tatsuo [1 ]
Fukuda, Yoshihiro [3 ]
Oda, Shigeto [2 ]
Yokosuka, Osamu [1 ]
机构
[1] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chiba 2608670, Japan
[2] Chiba Univ, Grad Sch Med, Dept Emergency & Crit Care Med, Chiba 2608670, Japan
[3] Seikeikai Chiba Med Ctr, Dept Gastroenterol, Chiba, Japan
[4] Shonan Fujisawa Tokushukai Hosp, Div Pathol, Fujisawa, Kanagawa, Japan
关键词
acute liver failure; fulminant hepatitis; severe hepatitis; unknown etiology; ACUTE LIVER-FAILURE; ONSET AUTOIMMUNE HEPATITIS; DISEASES STUDY-GROUP; DIAGNOSIS; AUTOANTIBODIES; PROGNOSIS; FEATURES;
D O I
10.1111/hepr.12483
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
AimThe outcome of acute liver failure (ALF) is influenced by its etiology, making etiological consideration of ALF important. However, specific etiology could not be identified in 30-40% of adult patients in a Japanese nationwide survey. We examined our patients with severe (SH) and fulminant hepatitis (FH) of indeterminate etiology for the better understanding of ALF. MethodsWe investigated 106 adult patients with SH or FH including 24 of indeterminate etiology between 2000 and 2013, retrospectively. ResultsOf 24 patients, 12 were men. Seventeen were SH and seven FH (three FH acute type and four FH subacute type). Eighty-three percent of patients were positive for antinuclear antibody. Seventeen recovered without liver transplantation (LT), two received LT and five died without LT. Histology of 15 patients showed a pattern of acute hepatitis (massive necrosis in four, submassive necrosis in one, severe acute hepatitis in two and acute hepatitis in eight). The involvement of immune-mediated liver injury was histologically suggested in some patients. ConclusionThere was no large cluster of etiology in our patients with indeterminate cause. The causes of ALF of indeterminate etiology were the mixture of various minor or rare ones, if precise diagnosis of acute AIH was done. Outcome of our patients with indeterminate cause was not poor if they were treated as early as possible after the diagnosis of severe disease. Careful examination of unknown viral infection, drugs, toxins, undefined metabolic disorders and histology may help detect some of these etiologies.
引用
收藏
页码:E141 / E149
页数:9
相关论文
共 50 条
  • [41] Immunosuppression in two cases of indeterminate hepatitis
    Cohen, Alexandra
    Alvarez, Fernando
    CANADIAN LIVER JOURNAL, 2024, 7 (01): : 64 - 69
  • [42] Prevalence of obesity in patients with acute hepatitis; Is severe obesity a risk factor for fulminant hepatitis in Japan?
    Kanda, T
    Yokosuka, O
    Hiraide, A
    Kojima, H
    Honda, A
    Fukai, K
    Imazeki, F
    Nagao, K
    Saisho, H
    HEPATO-GASTROENTEROLOGY, 2005, 52 (61) : 180 - 182
  • [43] The Role of Emerging and Neglected Viruses in the Etiology of Hepatitis
    Mrzljak, Anna
    Tabain, Irena
    Premac, Hrvoje
    Bogdanic, Maja
    Barbic, Ljubo
    Savic, Vladimir
    Stevanovic, Vladimir
    Jelic, Ana
    Mikulic, Danko
    Vilibic-Cavlek, Tatjana
    CURRENT INFECTIOUS DISEASE REPORTS, 2019, 21 (12)
  • [44] Lamivudine treatment is associated with improved survival in fulminant hepatitis B
    Yu, Jian-Wu
    Sun, Li-Jie
    Yan, Bing-Zhu
    Kang, Peng
    Zhao, Yong-Hua
    LIVER INTERNATIONAL, 2011, 31 (04) : 499 - 506
  • [45] Prognostic factors of fulminant hepatitis in pregnancy
    Li, XM
    Ma, L
    Yang, YB
    Shi, ZJ
    Zhou, SS
    CHINESE MEDICAL JOURNAL, 2005, 118 (20) : 1754 - 1757
  • [46] Fulminant hepatitis due to human adenovirus
    Ronan, B. A.
    Agrwal, N.
    Carey, E. J.
    De Petris, G.
    Kusne, S.
    Seville, M. T.
    Blair, J. E.
    Vikram, H. R.
    INFECTION, 2014, 42 (01) : 105 - 111
  • [47] Therapy of Acute and Fulminant Hepatitis B
    Tillmann, Hans L.
    Patel, Keyur
    INTERVIROLOGY, 2014, 57 (3-4) : 181 - 188
  • [48] Fulminant hepatitis due to human adenovirus
    B. A. Ronan
    N. Agrwal
    E. J. Carey
    G. De Petris
    S. Kusne
    M. T. Seville
    J. E. Blair
    H. R. Vikram
    Infection, 2014, 42 : 105 - 111
  • [49] Treatment with telbivudine for fulminant hepatitis B
    Lisotti, Andrea
    Eusebi, Leonardo H.
    Festi, Davide
    Bazzoli, Franco
    Mazzella, Giuseppe
    JOURNAL OF DIGESTIVE DISEASES, 2013, 14 (11) : 619 - 621
  • [50] Dengue causing fulminant hepatitis in a hepatitis B virus carrier
    Agarwal, Mukul P.
    Giri, Subhash
    Sharma, Vishal
    Roy, Ujjawal
    Gharsangi, Komal
    BIOSCIENCE TRENDS, 2011, 5 (01) : 44 - 45